Published in Gynecol Oncol on January 17, 2007
Targeting autophagy during cancer therapy to improve clinical outcomes. Pharmacol Ther (2011) 1.55
Soy isoflavones and prostate cancer: a review of molecular mechanisms. J Steroid Biochem Mol Biol (2013) 1.13
Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer. Cell Death Dis (2014) 1.08
A combination of indol-3-carbinol and genistein synergistically induces apoptosis in human colon cancer HT-29 cells by inhibiting Akt phosphorylation and progression of autophagy. Mol Cancer (2009) 1.06
Cancer prevention and therapy through the modulation of the tumor microenvironment. Semin Cancer Biol (2015) 0.97
Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaB. J Ovarian Res (2008) 0.93
RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway. Oncotarget (2015) 0.92
Macroautophagy: the key ingredient to a healthy diet? Autophagy (2009) 0.92
Genistein potentiates the antitumor effect of 5-Fluorouracil by inducing apoptosis and autophagy in human pancreatic cancer cells. Anticancer Res (2014) 0.85
Marchantin M: a novel inhibitor of proteasome induces autophagic cell death in prostate cancer cells. Cell Death Dis (2013) 0.84
Genistein as a Potential Anticancer Agent against Ovarian Cancer. J Tradit Complement Med (2012) 0.83
Modulation of inflammatory signaling pathways by phytochemicals in ovarian cancer. Genes Nutr (2011) 0.81
The flavonoid nobiletin inhibits tumor growth and angiogenesis of ovarian cancers via the Akt pathway. Int J Oncol (2015) 0.81
Genistein in 1:1 inclusion complexes with ramified cyclodextrins: theoretical, physicochemical and biological evaluation. Int J Mol Sci (2014) 0.81
All-trans retinoic acid and genistein induce cell apoptosis in OVCAR-3 cells by increasing the P14 tumor suppressor gene. Res Pharm Sci (2016) 0.75
Preliminary in vitro evaluation of genistein chemopreventive capacity as a result of esterification and cyclodextrin encapsulation. Anal Cell Pathol (Amst) (2015) 0.75
Parthenolide suppresses pancreatic cell growth by autophagy-mediated apoptosis. Onco Targets Ther (2017) 0.75
The Anti-Cancer Effect of Polyphenols against Breast Cancer and Cancer Stem Cells: Molecular Mechanisms. Nutrients (2016) 0.75
Cytotoxic activity of genistein-8-C-glucoside form Lupinus luteus L. and genistein against human SK-OV-3 ovarian carcinoma cell line. Med Chem Res (2016) 0.75
A High Concentration of Genistein Induces Cell Death in Human Uterine Leiomyoma Cells by Autophagy. Expert Opin Environ Biol (2016) 0.75
Vitamin K and its analogs: Potential avenues for prostate cancer management. Oncotarget (2017) 0.75
Gender differences in time spent on parenting and domestic responsibilities by high-achieving young physician-researchers. Ann Intern Med (2014) 4.76
Sex differences in attainment of independent funding by career development awardees. Ann Intern Med (2009) 4.62
Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol (2006) 3.79
A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma. Blood (2012) 3.44
Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys (2006) 3.40
Gender differences in salary in a recent cohort of early-career physician-researchers. Acad Med (2013) 2.68
Gender differences in the salaries of physician researchers. JAMA (2012) 2.66
Meta-analysis suggests that smoking is associated with an increased risk of early natural menopause. Menopause (2012) 2.36
Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys (2007) 2.33
A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas. Clin Cancer Res (2011) 2.24
Resveratrol-induced autophagocytosis in ovarian cancer cells. Cancer Res (2004) 2.20
How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes. Acta Biochim Biophys Sin (Shanghai) (2008) 2.19
Similarities and differences in the career trajectories of male and female career development award recipients. Acad Med (2011) 1.81
Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer. Cancer (2007) 1.76
Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node. Ann Surg Oncol (2006) 1.75
Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys (2010) 1.67
The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma. Cancer (2007) 1.64
(-)-gossypol inhibits growth and promotes apoptosis of human head and neck squamous cell carcinoma in vivo. Neoplasia (2006) 1.55
RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast. Breast Cancer Res Treat (2005) 1.49
Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy. Surgery (2007) 1.47
Expression of Bcl-xL in ovarian carcinoma is associated with chemoresistance and recurrent disease. Gynecol Oncol (2005) 1.45
High-risk surgically resected pediatric melanoma and adjuvant interferon therapy. Pediatr Blood Cancer (2005) 1.43
Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy. Cancer Res (2005) 1.41
Work-life balance in academic medicine: narratives of physician-researchers and their mentors. J Gen Intern Med (2013) 1.37
External-beam radiotherapy for localized extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys (2006) 1.33
Mentoring and the career satisfaction of male and female academic medical faculty. Acad Med (2014) 1.31
Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy. Breast Cancer Res Treat (2005) 1.30
Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors. Clin Cancer Res (2013) 1.20
Multistage genome-wide association meta-analyses identified two new loci for bone mineral density. Hum Mol Genet (2013) 1.17
Features predicting sentinel lymph node positivity in Merkel cell carcinoma. J Clin Oncol (2011) 1.16
A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer. Cancer (2013) 1.16
Evaluation of four techniques using intensity-modulated radiation therapy for comprehensive locoregional irradiation of breast cancer. Int J Radiat Oncol Biol Phys (2010) 1.13
Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance. Cancer Res (2002) 1.13
Cognitive-behavioral intervention for distress in patients with melanoma: comparison with standard medical care and impact on quality of life. Cancer (2003) 1.10
Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy. Breast Cancer Res Treat (2010) 1.10
Role of radiotherapy in the management of desmoid tumors. Int J Radiat Oncol Biol Phys (2010) 1.10
Resveratrol inhibits glucose metabolism in human ovarian cancer cells. Gynecol Oncol (2007) 1.09
Long-term outcomes after radiotherapy for retroperitoneal and deep truncal sarcoma. Int J Radiat Oncol Biol Phys (2007) 1.07
Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries. J Clin Oncol (2014) 1.06
Toxicity of radiotherapy in patients with collagen vascular disease. Cancer (2008) 1.06
Ginger inhibits cell growth and modulates angiogenic factors in ovarian cancer cells. BMC Complement Altern Med (2007) 1.04
Curcumin enhances Apo2L/TRAIL-induced apoptosis in chemoresistant ovarian cancer cells. Gynecol Oncol (2006) 1.04
Is there a dose-response relationship for heart disease with low-dose radiation therapy? Int J Radiat Oncol Biol Phys (2012) 1.04
Planning the breast tumor bed boost: changes in the excision cavity volume and surgical scar location after breast-conserving surgery and whole-breast irradiation. Int J Radiat Oncol Biol Phys (2006) 1.03
Stroke rates and risk factors in patients treated with radiation therapy for early-stage breast cancer. J Clin Oncol (2006) 1.03
Glucose deprivation activates AMPK and induces cell death through modulation of Akt in ovarian cancer cells. Gynecol Oncol (2011) 1.02
Analytic morphometric assessment of patients undergoing colectomy for colon cancer. J Surg Oncol (2013) 1.02
Conservative management of Paget disease of the breast with radiotherapy: 10- and 15-year results. Cancer (2003) 1.01
Physician and patient attitudes towards complementary and alternative medicine in obstetrics and gynecology. BMC Complement Altern Med (2008) 1.01
Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients. Cancer (2003) 1.00
Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Diagn Cytopathol (2006) 0.98
A Mixed-Methods Investigation of the Motivations, Goals, and Aspirations of Male and Female Academic Medical Faculty. Acad Med (2016) 0.98
The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas. Neurosurgery (2004) 0.96
A phase II study of preoperative capecitabine and radiation therapy in patients with rectal cancer. Am J Clin Oncol (2007) 0.96
Sporadic versus Radiation-Associated Angiosarcoma: A Comparative Clinicopathologic and Molecular Analysis of 48 Cases. Sarcoma (2013) 0.95
Gender differences in resources and negotiation among highly motivated physician-scientists. J Gen Intern Med (2014) 0.95
Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma? Cancer (2009) 0.94
Validation of statistical predictive models meant to select melanoma patients for sentinel lymph node biopsy. Ann Surg Oncol (2011) 0.94
A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancer. Invest New Drugs (2008) 0.93
Dose escalation for localized prostate cancer: substantial benefit observed with 3D conformal therapy. Int J Radiat Oncol Biol Phys (2003) 0.93
Targeting apoptosis to overcome cisplatin resistance: a translational study in head and neck cancer. Int J Radiat Oncol Biol Phys (2007) 0.93
Rate of freeze alters the immunologic response after cryoablation of breast cancer. Ann Surg Oncol (2009) 0.93
Correlates of mammogram density in southwestern Native-American women. Cancer Epidemiol Biomarkers Prev (2003) 0.90
Defective apoptosis underlies chemoresistance in ovarian cancer. Adv Exp Med Biol (2008) 0.90
Significance of multiple lymphatic basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy. Ann Surg Oncol (2006) 0.90
Long-term results of conservative surgery and radiotherapy for ductal carcinoma in situ using lung density correction: the University of Michigan experience. Breast J (2007) 0.89
The HIV protease inhibitor saquinavir induces endoplasmic reticulum stress, autophagy, and apoptosis in ovarian cancer cells. Gynecol Oncol (2009) 0.89
The identification of empirically derived cancer patient subgroups using psychosocial variables. J Psychosom Res (2004) 0.89
Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma. Cancer (2011) 0.88
Gemcitabine-based combination chemotherapy followed by radiation with capecitabine as adjuvant therapy for resected pancreas cancer. Int J Radiat Oncol Biol Phys (2009) 0.87
Accelerated partial breast irradiation: what is dosimetric effect of advanced technology approaches? Int J Radiat Oncol Biol Phys (2009) 0.87
Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site. Cancer (2007) 0.87
Relationship of mammographic parenchymal patterns to breast cancer risk factors and smoking in Alaska Native women. Cancer Epidemiol Biomarkers Prev (2003) 0.86
Is lobular carcinoma in situ as a component of breast carcinoma a risk factor for local failure after breast-conserving therapy? Results of a matched pair analysis. Cancer (2006) 0.86
Genome-wide copy number variation study and gene expression analysis identify ABI3BP as a susceptibility gene for Kashin-Beck disease. Hum Genet (2014) 0.86
Radiotherapy for pancreatic neuroendocrine tumors. Int J Radiat Oncol Biol Phys (2009) 0.85
Radiotherapy using a water bath in the treatment of Bowen's disease of the digit. Radiother Oncol (2008) 0.85
Neoadjuvant docetaxel and capecitabine and the use of thymidine phosphorylase as a predictive biomarker in breast cancer. Clin Cancer Res (2007) 0.85
Quantifying dose to the reconstructed breast: can we adequately treat? Med Dosim (2012) 0.85
The quality-of-life effects of neoadjuvant chemoradiation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys (2012) 0.85
Pathologic features of breast cancer associated with complete response to neoadjuvant chemotherapy: importance of tumor necrosis. Am J Surg Pathol (2005) 0.85
Perception and use of complementary and alternative medicine among gynecologic oncology care providers. Int J Gynaecol Obstet (2008) 0.84
Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma. Cancer (2007) 0.84
Long-term results of three-dimensional conformal adjuvant and salvage radiotherapy after radical prostatectomy. Urology (2003) 0.84
Clinicopathologic features of primary Merkel cell carcinoma: a detailed descriptive analysis of a large contemporary cohort. Dermatol Surg (2013) 0.83
Validation of tumor size as staging variable in the revised International Federation of Gynecology and Obstetrics stage I leiomyosarcoma: a population-based study. Int J Gynecol Cancer (2010) 0.83